| Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis K Bjornevik, M Cortese, BC Healy, J Kuhle, MJ Mina, Y Leng, SJ Elledge, ... Science 375 (6578), 296-301, 2022 | 1262 | 2022 |
| Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening DB Larremore, B Wilder, E Lester, S Shehata, JM Burke, JA Hay, ... Science advances 7 (1), eabd5393, 2021 | 1022* | 2021 |
| Rethinking Covid-19 test sensitivity—a strategy for containment MJ Mina, R Parker, DB Larremore New England Journal of Medicine 383 (22), e120, 2020 | 807 | 2020 |
| Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality MJ Mina, CJE Metcalf, RL De Swart, A Osterhaus, BT Grenfell Science 348 (6235), 694-699, 2015 | 451 | 2015 |
| To interpret the SARS-CoV-2 test, consider the cycle threshold value MR Tom, MJ Mina Clinical Infectious Diseases 71 (16), 2252-2254, 2020 | 429 | 2020 |
| Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens MJ Mina, T Kula, Y Leng, M Li, RD De Vries, M Knip, H Siljander, ... Science 366 (6465), 599-606, 2019 | 385 | 2019 |
| Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years CM Saad-Roy, CE Wagner, RE Baker, SE Morris, J Farrar, AL Graham, ... Science 370 (6518), 811-818, 2020 | 249 | 2020 |
| Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes CM Saad-Roy, SE Morris, CJE Metcalf, MJ Mina, RE Baker, J Farrar, ... Science 372 (6540), 363-370, 2021 | 212 | 2021 |
| COVID-19 testing: One size does not fit all MJ Mina, KG Andersen Science 371 (6525), 126-127, 2021 | 212 | 2021 |
| Estimating epidemiologic dynamics from cross-sectional viral load distributions JA Hay, L Kennedy-Shaffer, S Kanjilal, NJ Lennon, SB Gabriel, M Lipsitch, ... Science 373 (6552), eabh0635, 2021 | 171 | 2021 |
| Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward JE Bryant, AS Azman, MJ Ferrari, BF Arnold, MF Boni, Y Boum, K Hayford, ... Science immunology 5 (47), eabc6347, 2020 | 166 | 2020 |
| Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19 MJ Mina, TE Peto, M García-Fiñana, MG Semple, IE Buchan The Lancet 397 (10283), 1425-1427, 2021 | 164 | 2021 |
| JAM-A associates with ZO-2, afadin, and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier function AC Monteiro, R Sumagin, CR Rankin, G Leoni, MJ Mina, DM Reiter, ... Molecular biology of the cell 24 (18), 2849-2860, 2013 | 125 | 2013 |
| Drivers of airborne human-to-human pathogen transmission S Herfst, M Böhringer, B Karo, P Lawrence, NS Lewis, MJ Mina, ... Current opinion in virology 22, 22-29, 2017 | 121 | 2017 |
| Vaccine nationalism and the dynamics and control of SARS-CoV-2 CE Wagner, CM Saad-Roy, SE Morris, RE Baker, MJ Mina, J Farrar, ... Science 373 (6562), eabj7364, 2021 | 104 | 2021 |
| Reopening scenarios D Baqaee, E Farhi, MJ Mina, JH Stock National Bureau of Economic Research, 2020 | 93 | 2020 |
| Live Attenuated Influenza Vaccine Enhances Colonization of Streptococcus pneumoniae and Staphylococcus aureus in Mice MJ Mina, JA McCullers, K Keith P mBio 5 (1), e01040-13, 2014 | 91 | 2014 |
| The role of influenza in the severity and transmission of respiratory bacterial disease MJ Mina, KP Klugman The Lancet Respiratory Medicine 2 (9), 750-763, 2014 | 88 | 2014 |
| Seroepidemiologic study designs for determining SARS-COV-2 transmission and immunity H Clapham, J Hay, I Routledge, S Takahashi, M Choisy, D Cummings, ... Emerging infectious diseases 26 (9), 1978, 2020 | 84 | 2020 |
| Structural basis for antibody inhibition of flavivirus NS1–triggered endothelial dysfunction SB Biering, DL Akey, MP Wong, WC Brown, NTN Lo, H Puerta-Guardo, ... Science 371 (6525), 194-200, 2021 | 82 | 2021 |
Bryan GrenfellKathryn Briger and Sarah Fenton Professor of Ecology and Public Affairs, Princeton UniversityVerified email at princeton.edu
